The spin-off URV IngreDiZymes, third in the BBVA Innovation Award
IngreDiZymes, a spin-off from Universitat Rovira i Virgili, has won third prize in the fifth edition of the BBVA Award for Business Innovation in Tarragona. This emerging company stands out for turning proteins of natural origin into compounds that benefit health.
The award recognizes local talent and entrepreneurial spirit with a direct impact for the innovative university spin-off, which now has a media boost worth more than 6,000 euros and an annual subscription to the Diari de Tarragona.
The local value of IngreDiZymes and its innovation
What does IngreDiZymes do and why is it of interest to the province?
IngreDiZymes designs new ingredients for sectors such as food, cosmetics, and nutraceuticals, applying technology that uses natural proteins to create compounds beneficial for health. This directly impacts the circular economy of the region, as they reuse materials like chicken feet to generate solutions that can lower blood pressure or have antidiabetic effects.
Which patents and innovations stand out?
The spin-off holds patents that are applied to underexploited raw materials, turning waste into products with significant added value for the industry and local consumption. This approach provides a competitive advantage that can make a difference in key sectors for the Tarragona region.
The BBVA Award for Business Innovation: context and impact
What is the scope of this award in Tarragona?
The BBVA Awards, in collaboration with the Diari de Tarragona, seek to reward SMEs and freelancers based in the region who promote ideas aligned with the Sustainable Development Goals (SDGs). IngreDiZymes’ third place represents recognition with visibility and support that favors the consolidation of innovative projects in the territory.
Who has been part of the jury and which other companies have stood out?
The jury has included representatives from URV, BBVA, the Tarragona Chamber, and other local entities. It also awarded the company from l'Arboç Polar NanoPharma and the startup from Pratdip AlgaNova Biotech, reflecting the diversity and quality of the Tarragona innovation ecosystem.
How will this award affect the future of IngreDiZymes?
What value does the communication campaign add to the project?
The multichannel campaign valued at 6,000 euros and the subscription to the Diari de Tarragona offer IngreDiZymes a platform to expand its presence and attract new clients or investments, a key driver for growth in a highly competitive sector such as applied biotechnology.
What challenges and opportunities open up for this spin-off?
Besides consolidating its technology, IngreDiZymes can expand its range of applications and collaborate with other local industrial companies. This award is evidence that effort in local innovation can have a real global impact while transforming the economic reality of the region.
The reality is that IngreDiZymes clearly demonstrates that university research can become a business engine in Tarragona, providing real and sustainable solutions. With this trajectory, the spin-off not only adds another award but also consolidates its capacity to generate value in the short and long term.
Frequently Asked Questions
- What is IngreDiZymes and what does it do?
- It is a URV spin-off that transforms natural proteins into compounds beneficial for health, aimed at food, cosmetics, and nutraceuticals.
- Which award has IngreDiZymes won?
- It has won third place at the BBVA Award for Business Innovation in Tarragona, with a communication campaign valued at 6,000 euros.
- How does this award help the spin-off?
- The media boost and visibility that the campaign provides facilitate attracting clients and investors, key for its expansion and development.
Source of the article: Universitat Rovira i Virgili
